Immune thrombocytopenia: improving quality of life and patient outcomes
Immune thrombocytopenia (ITP) is an immune-mediated disorder characterized by a reduced platelet count and patients may develop bruising or mucosal bleeding. Since 2003, generic health-related quality of life (HRQoL) measures have been applied and ITP-specific ...
Patient Relat Outcome Meas . 2018 Nov 27;9:369–384. doi: 10.2147/PROM.S140932 Immune thrombocytopenia: improving quality of life and patient outcomes Patrick Trotter Patrick Trotter 1 Department of Surgery, University of Cambridge, Cambridge, UK 2 National Health Service Blood and Transplant, Organ Donation and Transplant Directorate, Bristol, UK Find articles by Patrick Trotter 1, 2 , Quentin A Hill Quentin A Hill 3 Department of Haematology, St James’s University Hospital, Leeds, UK, quentinhill@nhs.net Find articles by Quentin A Hill 3, ✉ Author information Article notes Copyright and Licen
Explore this link on the map →related reading
- Lupus - Wikipediaen.wikipedia.org
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Acquired Hemophilia A - Symptoms, Causes, Treatment | NORDrarediseases.org
- UpToDateuptodate.com
- UpToDateuptodate.com
- Thyrotoxic Periodic Paralysis(Archived) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp
- Notionnotion.so
- Notionnotion.so
- Locked-in Syndrome and the Misplaced Presumption of Miseryundark.org
- Unmet Needs Index — Biopharma Disease Prioritizationinsights.convoke.bio